Important notification
24.02.2016 To the attention of interested persons Related to NAMMD notification of 27 January 2016, on technical requirements for NAMMD […]
24.02.2016 To the attention of interested persons Related to NAMMD notification of 27 January 2016, on technical requirements for NAMMD […]
17.02.2016 To the attention of interested persons EMA press release on SGLT2 inhibitors: PRAC makes recommendations to minimise risk of […]
17.02.2016 To the attention of interested persons EMA press release on updated recommendations to minimise the risk of the rare […]
16.02.2016 To the attention of interested persons EMA press release: PRAC recommends that fusafungine nose and mouth sprays are no […]
15.02.2016 To the attention of interested parties The European Commission, the European Medicines Agency (EMA) and national competent authorities of […]
09.02.2016 To the attention of interested persons Press release: EMA concludes defective device in ROCKET study does not impact Xarelto’s […]
09.02.2016 To the attention of interested persons Press release: EMA sets up task force on Zika virus download document …
02.02.2016 To the attention of interested persons EMA press release: Review of metformin-containing medicines started download document …
28.01.2016 To the attention of interested persons Based on provisions of Article 35 of Order of the Minister of Health […]
27.01.2016 To the attention of interested parties Use of electronic forms for applications for authorisation, renewal, variations (electronic Application Form, […]